Navigation Links
Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors
Date:5/16/2013

d markets

• 2012 Sales of branded long-acting recombinant human insulin analogs in regulated markets

• Rhu insulin (2nd generation) in regulated markets

• Biosimilar rhu insulin (2nd generation) in regulated markets

• Rhu insulin analogs (3rd generation) in regulated markets

• Biosimilar rhu insulin analogs (3rd generation) in regulated markets

• Ultra-long acting rhu insulin formulations and insulin analogs (4th generation)

• Ultra-fast acting rhu insulin formulations and insulin analogs (4th generation)

• Combinations of modern basal and prandial insulin & analogs (4th generation)

• Combinations of insulin & GLP-1 agonist (4th generation)

• Other combinations with insulin

• Oral and Transbuccal Insulins (5th generation)

• Inhaled and transdermal insulin

• Novel approaches for insulin therapy

 

Rhu insulin (2nd generation) in non-regulated markets: India

• Rhu insulin (2nd generation) in non-regulated markets: China

• Rhu insulin (2nd generation) in non-regulated markets: Other Territories

• Modern insulin analogs (3rd generation) in non-regulated markets

• Animal insulins (1st generation)

 

6 ) Coagulation Factors

 

• Sales of Recombinant Coagulation Factors for Hemophilia in 2012

• Human Plasma-Derived Coagulation Factor VIII Concentrates

• Recombinant Coagulation Factor VIII

• Human Plasma-Derived Coagulation Factor IX

• Recombinant Coagulation Factor IX

• Human Plasma-Derived Factor VII

• Recombinant Coagulation Factor VII

• Human Plasma-Derived Coagulation Factor Concentrates for Willebrand Disease

• Recombinant Hu
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Cell Therapeutics to Present at Upcoming Investor Conferences
2. Orexigen Therapeutics to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
3. ASGCT Annual Meeting to Highlight Latest Advances in Genetic and Cellular Therapeutics
4. Orexigen Therapeutics Reports Financial Results for the First Quarter Ended March 31, 2013
5. Emergent Technologies and Caisson Biotech Form Strategic Alliance with Local Health Care Providers to Improve Delivery and Performance of a Therapeutic Drug
6. Henri A. Termeer Joins Moderna Therapeutics Board Of Directors
7. Oxford BioTherapeutics and Boehringer Ingelheim Enter Collaboration to Discover Novel Antibody Targets in Cancer
8. Orexigen Therapeutics Commends the Campaign to End Obesitys Report on Long-term Returns of Obesity Prevention Policies
9. Cell Therapeutics to Report First Quarter Financial Results after Market on May 2, 2013
10. United Therapeutics Corporation To Announce First Quarter 2013 Financial Results Before Market Open On Thursday, April 25, 2013
11. Nanotherapeutics Awarded Defense Department Contract for Advanced Development and Manufacturing of Medical Countermeasures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... EquitiesIQ, a leading informational research provider, has ... an emerging biomedical company acquiring, developing, manufacturing, and marketing ... Free report download: http://equitiesiq.com/reports/alliqua/ , In late ... and Board, which launched the company’s new strategy to ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 In recent ... motives and methods in product development and promotion has ... industry. This mistrust, fueled by concerns about the insidious ... by reports of spectacular fines to the world’s biggest ...
(Date:1/14/2014)... Bellingham, Washington, USA, and Cardiff, UK (PRWEB) January 13, ... and photonics technology development leader with more than 20 ... international society for optics and photonics . Hainsey will ... “We are delighted to have Dr. Hainsey join SPIE ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 BioMedomics, Inc. ... ultra-sensitive POC diagnostic platforms and novel disease specific POC tests, ... of financing netting a total of $690,000. The investment is ... in the company. This group of private investors has significant ...
Breaking Biology Technology:EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff 2BioMedomics, Inc. Closes $690K Round of Financing 2
... Ltd. (Amex:,SVA), a leading provider of vaccines in ... Qualifications Department at the American Stock,Exchange that the ... no later than April 30, 2008., The ... August 2007. The meeting was postponed because the ...
... SAN DIEGO, Dec. 13 /PRNewswire-FirstCall/ - MIGENIX ... of drugs for infectious,diseases, reports financial results ... and an update on its programs., ... 1% gel (Omigard(TM)/CPI-226/MX-226; topical cationic peptide;,prevention of ...
... validation studies,were published during 2007 on the Simbionix ... of studies published to 65., "This year ... from US and,European institutes" said Gary Zamler, Simbionix, ... medical institutions and teaching hospitals,have completed studies measuring ...
Cached Biology Technology:Sinovac Requests Extension for Annual Shareholders Meeting 2MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 2MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 3MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 4MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 5MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 6MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 7MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 8MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 9MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 10MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 11MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 12MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 13MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 14MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 15MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 16MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 17MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 182007 a "Record Year" for Successful Validation Studies of Simbionix Simulators 2
(Date:4/23/2014)... HUNTSVILLE, TX (4/23/14) -- Researchers have found evidence ... risk factors that increase aggressive behavior in children, ... that not all children exposed to prenatal smoking ... others will not," said Brian Boutwell, Assistant Professor ... Justice and senior author on the study. ...
(Date:4/23/2014)... yesterday, Argentina joins the European Molecular Biology Laboratory ... strengthens the ties between the European and Latin ... access to EMBL,s world-class facilities and programs, and ... inception, fostering excellent life science research and promoting ... EMBL,s mission," says EMBL Director General Iain Mattaj ...
(Date:4/23/2014)... newly coined term for novels and films which focus on ... Copenhagen shows how these fictions serve as a mental laboratory ... change and imagine other living conditions. , "Global warming ... atmosphere; it is also a cultural phenomenon in which meaning ... films we see. And there are so many of them ...
Breaking Biology News(10 mins):Genetics risk, prenatal smoking may predict behavioral problems 2Fiction prepares us for a world changed by global warming 2Fiction prepares us for a world changed by global warming 3
... August 9, 2011 A newly-identified protein may hold ... check, according to a study by York University researchers. ... Biology, Faculty of Science & Engineering, is delving into ... present in the brain. His studies found that rats ...
... is available in German . During the ... humans, chromosomes are broken and rearranged at many positions. Using ... Klein, professor for genetics at the Max F. Perutz Laboratories ... high resolution. The surprising observations regarding the mechanism of meiosis ...
... LANSING, Mich. --- Lakes, streams and wetlands are not ... her colleagues are pioneering a new field of research ... surroundings. Patricia Soranno, associate professor of fisheries and ... grant to gauge land use and climate change,s impact ...
Cached Biology News:York U researchers zero in on protein that may help treat obesity, diabetes 2The machinery for recombination is part of the chromosome structure 2The machinery for recombination is part of the chromosome structure 3MSU professor launches new field of water research, nets $2.2 million NSF grant 2
... leader in electroporation products and specialty electrodes, ... line for experiment optimization and large volume ... breakthrough in Molecular Delivery. The days of ... typically limited the number of samples and ...
... Sequencer 20 System revolutionizes DNA sequencing, delivering ... The Genome Sequencer 20 System includes: ... and consumables for library construction, amplification, and ... de novo assembly The ...
... and size analyzer offering a wide dynamic range. ... in mind. It is comprised of a chemically ... The system is completely computer controlled. The modular ... such as dry or where smaller volumes are ...
... Kit provides a fast and simple procedure for ... other detergents from small samples of protein. The ... resin as an ion exchanger. Each column is ... acidic or basic protein.A complete kit for acidic ...
Biology Products: